Janssen’s Tremfya (guselkumab) receives its first two positive Health Technology Assessments in Europe Read more
Asterias Biotherapeutics Announces First Patient Dosed in First-in-Human Clinical Study of Immunotherapy AST-VAC2 in Non-Small Cell Lung Cancer Read more
GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs Read more
Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement Read more